NCT00294086View on ClinicalTrials.gov

A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure

PHASE2CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Chronic Heart Failure

Interventions

DRUG

valsartan 160 mg

DRUG

valsartan 160 mg BID

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY